Yatomi Y, Ozaki Y, Satoh K, Kume S
Department of Laboratory Medicine, Yamanashi Medical College, Japan.
Biochim Biophys Acta. 1994 Jun 2;1212(3):337-44. doi: 10.1016/0005-2760(94)90208-9.
To elucidate the mechanism involving synthesis of phosphatidylinositol 3,4-bisphosphate (PtdIns(3,4)P2), which is the main species of 3-phosphorylated phosphoinositides in activated blood platelets, we observed a correlation among protein-tyrosine phosphorylation, protein kinase C (PKC) activation, and PtdIns(3,4)P2 synthesis in these anucleate cells. Thrombin (1 U/ml) elicited marked protein-tyrosine phosphorylation, PKC activation, and PtdIns(3,4)P2 synthesis. In contrast, 1 microM 12-O-tetrade-canoylphorbol 13-acetate barely induced tyrosine phosphorylation and PtdIns(3,4)P2 synthesis although it strongly activated PKC. A variety of kinase inhibitors were tested for their ability to inhibit the thrombin effects. Both staurosporine and tyrphostin inhibited thrombin-stimulated tyrosine phosphorylation and PtdIns(3,4)P2 synthesis. H-7, which specifically, although weakly, inhibited PKC activation, had no effect on tyrosine phosphorylation and PtdIns(3,4)P2 production. Among the various kinase inhibitors tested, staurosporine was the most potent inhibitor of protein tyrosine phosphorylation and PtdIns(3,4)P2 synthesis, and there was a good correlation of the inhibition between these two parameters, although it also inhibited PKC activation. To examine the involvement of PtdIns 3-kinase, which is believed to play an important role in 3-phosphorylated phosphoinositide synthesis, we studied tyrosine phosphorylation and the association with tyrosine-phosphorylated proteins of the p85 alpha subunit of PtdIns 3-kinase in thrombin-stimulated platelets. We did not detect tyrosine-phosphorylated protein by Western blotting where p85 alpha was located. Similarly, when platelet lysates were precipitated with anti-p85 alpha antibodies and then blotted with anti-phosphotyrosine antibodies, tyrosine-phosphorylated p85 alpha was undetectable. Furthermore, when the cell lysates were precipitated with anti-phosphotyrosine antibodies, no p85 alpha was found in the immunoprecipitates. These results show that PtdIns(3,4)P2 synthesis in stimulated platelets is mediated by tyrosine phosphorylation, as it is in proliferating cells, but the p85 alpha subunit of PtdIns 3-kinase may not be a target for tyrosine kinases and that staurosporine, though non-specific, would be a useful tool for elucidating signal transduction involving D-3-phosphorylated phosphoinositide generation and protein-tyrosine phosphorylation in blood platelets.
为阐明涉及磷脂酰肌醇3,4 - 二磷酸(PtdIns(3,4)P2)合成的机制,PtdIns(3,4)P2是活化血小板中3 - 磷酸化磷酸肌醇的主要类型,我们观察了这些无核细胞中蛋白质酪氨酸磷酸化、蛋白激酶C(PKC)活化与PtdIns(3,4)P2合成之间的相关性。凝血酶(1 U/ml)引起显著的蛋白质酪氨酸磷酸化、PKC活化和PtdIns(3,4)P2合成。相比之下,1 microM 12 - O - 十四烷酰佛波醇13 - 乙酸酯虽然强烈激活PKC,但几乎不诱导酪氨酸磷酸化和PtdIns(3,4)P2合成。测试了多种激酶抑制剂抑制凝血酶作用的能力。星形孢菌素和 tyrphostin均抑制凝血酶刺激的酪氨酸磷酸化和PtdIns(3,4)P2合成。H - 7特异性地(尽管较弱)抑制PKC活化,但对酪氨酸磷酸化和PtdIns(3,4)P2生成无影响。在测试的各种激酶抑制剂中,星形孢菌素是蛋白质酪氨酸磷酸化和PtdIns(3,4)P2合成的最有效抑制剂,并且这两个参数之间的抑制存在良好的相关性,尽管它也抑制PKC活化。为研究被认为在3 - 磷酸化磷酸肌醇合成中起重要作用的磷脂酰肌醇3 - 激酶的参与情况,我们研究了凝血酶刺激的血小板中磷脂酰肌醇3 - 激酶p85α亚基的酪氨酸磷酸化及其与酪氨酸磷酸化蛋白的结合。我们通过蛋白质印迹法在p85α所在位置未检测到酪氨酸磷酸化蛋白。同样,当用抗p85α抗体沉淀血小板裂解物,然后用抗磷酸酪氨酸抗体印迹时,未检测到酪氨酸磷酸化的p85α。此外,当用抗磷酸酪氨酸抗体沉淀细胞裂解物时,在免疫沉淀物中未发现p85α。这些结果表明,刺激的血小板中PtdIns(3,4)P2的合成如在增殖细胞中一样由酪氨酸磷酸化介导,但磷脂酰肌醇3 - 激酶的p85α亚基可能不是酪氨酸激酶的作用靶点,并且星形孢菌素尽管是非特异性的,但将是阐明血小板中涉及D - 3 - 磷酸化磷酸肌醇生成和蛋白质酪氨酸磷酸化的信号转导的有用工具。